camptothecin has been researched along with methylselenic acid in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alcolea, V; Encío, I; Palop, JA; Plano, D; Sanmartín, C; Sharma, AK | 1 |
Hu, H; Ip, C; Jiang, C; Lü, J; Rustum, YM | 1 |
2 other study(ies) available for camptothecin and methylselenic acid
Article | Year |
---|---|
Chalcogen containing heterocyclic scaffolds: New hybrids with antitumoral activity.
Topics: Antineoplastic Agents; Cell Cycle Checkpoints; Cell Death; Cell Line, Tumor; Cell Proliferation; Chalcogens; Drug Screening Assays, Antitumor; Heterocyclic Compounds; Humans; Structure-Activity Relationship | 2016 |
Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Topics: Androgens; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Caspases; Drug Therapy, Combination; Enzyme Activation; Etoposide; Humans; JNK Mitogen-Activated Protein Kinases; Male; Organoselenium Compounds; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Phosphorylation; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Tumor Cells, Cultured | 2005 |